SPRY
ARS Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website ars-pharma.com
- Employees(FY) 24
- ISIN US82835W1080
Performance
+2.61%
1W
-1.63%
1M
+25.94%
3M
+100.22%
6M
+64.78%
YTD
+8.93%
1Y
Profile
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions. It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including anaphylaxis. The company was founded in 2015 and is based in San Diego, California.
Investment Analysis Report: SPRY
Overview:
SPRY is a company operating in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $688.3 million. In this report, we will conduct a comprehensive analysis of SPRY's financial statements to evaluate its valuation, financial health...
Technical Analysis of SPRY 2024-05-10
Overview:
In analyzing the technical indicators for SPRY over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to gain a comprehensive understanding of the stock's potential price movement. By examining these key factors, we can form a well-rounded prediction for the next few days.
Trend Analysis:
- Movin...
Recent News & Updates
- 2024-05-12 21:01
- 2024-05-11 08:24
- 2024-05-09 16:05
- 2024-05-09 11:54
- 2024-05-09 04:05
- 2024-04-30 09:01
- 2024-04-29 21:01
- 2024-04-05 18:30
- 2024-04-03 09:01
- 2024-04-03 07:15
- 2024-04-02 21:01
- 2024-04-01 12:00
- 2024-04-01 00:00
- 2024-03-26 08:50
- 2024-03-25 20:50
- 2024-03-21 17:33
- 2024-03-21 16:05
- 2024-03-21 10:53
- 2024-03-21 04:05
- 2024-03-15 06:00
- 2024-03-07 16:05
- 2024-03-07 03:05
- 2024-03-06 09:01
- 2024-03-05 20:01
- 2024-02-26 09:01
- 2024-02-25 20:01
- 2024-02-22 09:01
- 2024-02-22 05:33
- 2024-02-21 20:01
- 2024-02-20 09:01
Page 1 of 3
previousnext